Autoimmune Hepatitis in a Patient with Pulmonary Arterial Hypertension Treated with Endothelin Receptor Antagonists-Reference-Cited by-同舟云学术

Autoimmune Hepatitis in a Patient with Pulmonary Arterial Hypertension Treated with Endothelin Receptor Antagonists

Published:2014 Issue:7 Volume:53 Page:771-775
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Naito Akira¹,Terada Jiro¹,Tanabe Nobuhiro¹,Sugiura Toshihiko¹,Sakao Seiichiro¹,Kanda Tatsuo²,Yokosuka Osamu²,Tatsumi Koichiro¹

Affiliation:

1. Department of Respirology, Graduate School of Medicine, Chiba University, Japan

2. Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/53/7/53_53.1362/_pdf

Reference17 articles.

1. 1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54: S43-S54, 2009.

2. 2. Hartman JC, Brouwer K, Mandagere A, Melvin L, Gorczynski R. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. Can J Physiol Pharmacol 88: 682-691, 2010.

3. 3. Hoeper MM. Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy? Eur Respir J 34: 529-530, 2009.

4. 4. Fattinger K, Funk C, Pantze M, et al. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther 69: 223-231, 2001.

5. 5. Imbach P. Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review. Swiss Med Wkly 142: w13593, 2012.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of the implementation of risk minimization measures for bosentan: a retrospective study;Expert Opinion on Drug Safety;2024-08-22

2. Medikamentös-toxischer Leberschaden (DILI);Pathologie;2020

3. Bosentan Inducing Autoimmune Hepatitis in a Patient with Idiopathic Pulmonary Arterial Hypertension;Journal of Gastrointestinal and Liver Diseases;2018-03-31

4. Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension;Endocrine Journal;2017

5. Ambrisentan☆;Reference Module in Biomedical Sciences;2017